000 | 01471 a2200409 4500 | ||
---|---|---|---|
005 | 20250515193131.0 | ||
264 | 0 | _c20100205 | |
008 | 201002s 0 0 eng d | ||
022 | _a1476-4598 | ||
024 | 7 |
_a10.1186/1476-4598-8-94 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBhuvaneswari, Ramaswamy | |
245 | 0 | 0 |
_aTargeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response. _h[electronic resource] |
260 |
_bMolecular cancer _cNov 2009 |
||
300 |
_a94 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCetuximab |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 | _aPhotochemotherapy |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aGan, Yik Yuen | |
700 | 1 | _aSoo, Khee Chee | |
700 | 1 | _aOlivo, Malini | |
773 | 0 |
_tMolecular cancer _gvol. 8 _gp. 94 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1476-4598-8-94 _zAvailable from publisher's website |
999 |
_c19267302 _d19267302 |